The Latest Breaking News from Medtronic

Medtronic is poised to release its fiscal third-quarter earnings next month, and analysts project a single-digit profit growth.

Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee osteoarthritis.

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

Although Medtronic has lagged behind the broader S&P 500 index over the past three months, analysts remain moderately optimistic about the stock’s prospects.

The Dividend Aristocrats offer reliable yields; buying them when they are down provides a lever for total returns and a vehicle for market-beating returns.

Medtronic's stock price is in a classic head-and-shoulders reversal that could take it back to record highs within the next two years.

Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in early trading.

December S&P 500 E-Mini futures (ESZ24) are down -0.40%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.32% this morning as risk sentiment took a hit after Russian President Vladimir Putin updated the country’s nuclear doctrine, while investors awaited fresh data on the U.S. housing market and an earnings…